Adjuvant docetaxel for node-positive breast cancer. - Martin M; Pienkowski T; Mackey J; Pawlicki M; Guastalla J; Weaver C; Tomiak E; Al-Tweigeri T; Chap L; Juhos E; Guevin R; Howell A; et al. (New England Journal of Medicine, 2005)